Page last updated: 2024-09-05

ezlopitant and granisetron

ezlopitant has been researched along with granisetron in 1 studies

Compound Research Comparison

Studies (ezlopitant)	Trials (ezlopitant)	Recent Studies (post-2010) (ezlopitant)	Studies (granisetron)	Trials (granisetron)	Recent Studies (post-2010) (granisetron)
22	2	1	1,149	466	243

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachinsky, ME; DelPrete, S; Dirlam, NL; Gralla, RJ; Hesketh, PJ; Silberman, SL; Stack, CB; Ueno, W; Webb, RT	1

Trials

1 trial(s) available for ezlopitant and granisetron

Article	Year
Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzene Derivatives; Cisplatin; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Vomiting	1999

Article

Year

Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1

Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzene Derivatives; Cisplatin; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Vomiting

1999